GATA2 deficiency underlying severe blastomycosis and fatal herpes simplex virus–associated hemophagocytic lymphohistiocytosis - 05/02/16

| This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, under project Z01-AI-00647-25. |
|
| Disclosure of potential conflict of interest: J. S. Orange has received consultancy fees from Baxter Healthcare, ADMA Biologics, ASD Healthcare, CSL Behring, and Atlantic Research; has provided expert testimony for the State of Arizona; has received research support and lecture fees from CSL Behring; has patents with Children's Hospital of Philadelphia; and has received royalties from UpToDate, Springer, and UniMed. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 137 - N° 2
P. 638-640 - février 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
